Hypertension trials recruiting in Mississippi

All Hypertension trials nationally

Cities in Mississippi

Recruiting trials in Mississippi

• A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
  NCT06649110 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 100 Years · Sex: All (male and female) · Mississippi: Ridgeland
• EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
  NCT07064473 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Mississippi: Fayette
• Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL
  NCT06468202 · Phase: Phase 4 · Ages: 14 Years to 35 Years · Sex: Female · Mississippi: Jackson
• Jackson Heart Study Women's Hypertension Study
  NCT06511479 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 99 Years · Sex: Female · Mississippi: Jackson
• Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
  NCT06911632 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Mississippi: Jackson
• Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
  NCT04278404 · Phase: Not specified · Ages: 0 Years to 20 Years · Sex: All (male and female) · Mississippi: Jackson, Madison
• Progesterone to Enhance the Efficacy and Success of Expectantly Managed Preterm Severe/Superimposed Preeclampsia
  NCT02989025 · Phase: Phase 2 · Ages: 18 Years to 45 Years · Sex: Female · Mississippi: Jackson
• SPYRAL GEMINI Pilot Study
  NCT06907147 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · Mississippi: Tupelo
• THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension
  NCT06559891 · Phase: Not applicable (e.g. observational or device study) · Ages: 22 Years to 75 Years · Sex: All (male and female) · Mississippi: Gulfport, Jackson
• Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
  NCT07181109 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Mississippi: Jackson, Olive Branch, Port Gibson, Ridgeland